RedHill’s Opaganib Approved by FDA to Combat Neuroblastoma
Key Takeaways
- The orphan drug status ensures seven years of market exclusivity for opaganib upon FDA approval.
- Opaganib's mechanism of action targets multiple cellular...
Innovative Endometriosis Diagnosis: ACT ENDO Challenge Targets Non-Invasive Solutions
The RADx Tech ACT ENDO Challenge, led by NIH’s Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National...
New Artificial Intelligence Tool Predicts Response to Immunotherapy Using Routine Clinical Data
A significant advancement in the fight against cancer has emerged with the development of a novel artificial intelligence (AI) tool designed to predict patient...
Proposed NIH Reforms Aim to Improve Conditions for Postdoctoral Researchers
MAT -
A working group from the National Institutes of Health (NIH) has proposed changes intended to enhance conditions for postdoctoral researchers in academia. This initiative...
NIH Awards $9.7 Million for Medical Research Projects Using All of Us Program Data
MAT -
The National Institutes of Health (NIH) has granted $9.7 million to fund 26 research projects over two years. This funding aims to boost research...
